371 related articles for article (PubMed ID: 22326484)
1. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma.
Ivanova JI; Bergman R; Birnbaum HG; Colice GL; Silverman RA; McLaurin K
J Allergy Clin Immunol; 2012 May; 129(5):1229-35. PubMed ID: 22326484
[TBL] [Abstract][Full Text] [Related]
2. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
3. Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data.
O'Connor RD; Bleecker ER; Long A; Tashkin D; Peters S; Klingman D; Gutierrez B
J Asthma; 2010 May; 47(4):422-8. PubMed ID: 20528597
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
Lage MJ; Gross GN; Brewster C; Spalitto A
Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
[TBL] [Abstract][Full Text] [Related]
5. Ratio of controller to total asthma medications: determinants of the measure.
Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
[TBL] [Abstract][Full Text] [Related]
6. Asthma costs and utilization in a managed care organization.
Zeiger RS; Hay JW; Contreras R; Chen W; Quinn VP; Seal B; Schatz M
J Allergy Clin Immunol; 2008 Apr; 121(4):885-92.e5. PubMed ID: 18313133
[TBL] [Abstract][Full Text] [Related]
7. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
Luskin A; Bukstein D; Kocevar VS; Yin DD
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis.
Han C; Lofland JH; Zhao N; Schenkel B
J Drugs Dermatol; 2011 Aug; 10(8):843-50. PubMed ID: 21818505
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
[TBL] [Abstract][Full Text] [Related]
10. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
11. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
[TBL] [Abstract][Full Text] [Related]
12. Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma.
Lane SJ; Petersen H; Seltzer JM; Blanchette CM; Navaratnam P; Allen-Ramey F; Fuhlbrigge A
J Asthma; 2013 Aug; 50(6):642-8. PubMed ID: 23514102
[TBL] [Abstract][Full Text] [Related]
13. Asthma severity categorization using a claims-based algorithm or pulmonary function testing.
Birnbaum HG; Ivanova JI; Yu AP; Hsieh M; Seal B; Emani S; Rosiello R; Colice GL
J Asthma; 2009 Feb; 46(1):67-72. PubMed ID: 19191141
[TBL] [Abstract][Full Text] [Related]
14. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
15. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
16. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting.
Chastek B; Korrer S; Nagar SP; Albers F; Yancey S; Ortega H; Forshag M; Dalal AA
J Manag Care Spec Pharm; 2016 Jul; 22(7):848-61. PubMed ID: 27348285
[TBL] [Abstract][Full Text] [Related]
17. Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals.
Kim SH; Kim TW; Kwon JW; Kang HR; Lee YW; Kim TB; Kim SH; Park HW; Park SW; Chang YS; Cho YS; Park JW; Cho YJ; Yoon HJ; Cho SH; Choi BW; Moon HB; Min KU
J Asthma; 2012 Apr; 49(3):303-9. PubMed ID: 22185405
[TBL] [Abstract][Full Text] [Related]
18. The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care.
Smith JR; Noble MJ; Musgrave S; Murdoch J; Price GM; Barton GR; Windley J; Holland R; Harrison BD; Howe A; Price DB; Harvey I; Wilson AM
Thorax; 2012 Dec; 67(12):1052-60. PubMed ID: 22941976
[TBL] [Abstract][Full Text] [Related]
19. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
